Rise in incidence of chronic diseases followed by patients’ shift toward advanced delivery systems are the factors basically responsible for the growth of on-body drug delivery devices market. On-body drug delivery devices help in determining more predictable drug levels along with reduction in variability in response to the treatment.
The companies operating in the on-body drug delivery devices market are working toward launching more efficient on-body delivery systems for injectables. They are also exploring the launch of multifunctional system in order to send drugs where they could be effective in the body’s organs and tissues.
An on-body drug delivery device is a patched-on device delivering big molecules (biologics) subcutaneously and has been designed for therapies that periodically need a specific quantity of formulated drug. Typical applications comprise proteins such as monoclonal antibodies (mAbs).
The advantages offered by on-body drug delivery devices include higher level of precision at lower dosing increments, home-use with bolus and/or basal profile, automatic needle insertion and retraction, occlusion detection, resusable/disposable concept supporting sustainability, and use of standard glass cartridges.
Research states that targeted drug delivery results in enhanced pharmacokinetics such as improved absorption, distribution, metabolism, and excretion (ADME).
| Attribute | Detail |
|---|---|
| Market Drivers |
|
The basic advantage of advanced drug delivery system is that it is able to accurately target specific cells/tissues, thereby minimizing the side-effects of drugs and increasing the therapeutic efficacy.
Drug delivery technologies have proven to enhance treatment outcomes in various ways, which include enhancement of therapeutic efficacy, increasing patient compliance, reducing toxicity, and facilitating novel medical treatments.
The advanced drug delivery systems include proteic, lipidic, and polymeric technologies for providing newly sustained drug delivery with higher level of drug protection from harsher external environment.
It could thus be inferred that advanced drug delivery systems constitutes sustained drug delivery, rapid drug delivery, and highly efficient drug delivery.
Targeted drug delivery systems are capable of concentrating a medicine’s active ingredient at site of a lesion/anatomical target, and keep the drug at effective concentration on targeted organ for longer duration, thereby facilitating prescription of medicines at lower dose.
On-body drug delivery devices help in obtaining enhanced drug safety along with patient compliance. These devices are designed such that therapeutic levels of drug are maintained, and side-effects and overdose of drugs can be reduced. Besides, drugs can be delivered with short in-vivo half-lives.
As per the WHO, noncommunicable diseases (NCDs) end up killing 41 million people every single year, which is equivalent to 74% of all the fatalities at the global level.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest on-body drug delivery devices market analysis, North America led the solid dose drug formulation landscape in 2023 and the scenario is expected to remain unchanged during the forecast period.
This is attributed to growing demand for advanced drug delivery systems such as metered-dose inhalers and sensor-embedded devices. As per study published by CIHI in April 2021, more than 3 million acute inpatient hospitalizations were witnessed in Canada in 2019-2020.
Europe’s significant on-body drug delivery devices market growth is ascribed to rise in awareness about advanced drug delivery devices and rise in adoption of the advanced products.
Moreover, various clinical trials are being conducted regularly for novel products and introduction of new products by the key participants. Along these lines, in April 2021, Medtronic launched its extended infusion set in select European nations. It can be worn for close to a week.
The key participants in the on-body drug delivery devices market are launching new products to strengthen their position. For instance, in September 2023, Corium, Inc. introduced ADLARITY, a donepezil transdermal system in the U.S. to treat patients contracting mile-to-severe Alzheimer’s.
In August 2022, Baxter announced that it had obtained clearance from the U.S. FDA for usage of Novum IQ Syringe Infusion Pump with Dose IQ Safety Software. These infusion pumps deliver small quantities of fluid at low rates in neonatal, pediatric, or anesthesia care settings with utmost precision.
Enable Injections, Inc., NOVO Engineering, Elcam Medical, Battelle, and Gerresheimer AG are some of the key players covered in the on-body drug delivery devices market report.
These companies have been profiled based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 390.7 Mn |
| Market Forecast (Value) in 2034 | US$ 796.1 Mn |
| Growth Rate (CAGR) | 6.8% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 390.7 Mn in 2023
It is projected to grow at a CAGR of 6.8% from 2024 to 2034
Patients’ shift toward advanced drug delivery systems and rise in incidence of chronic diseases
Hospitals segment accounted for the largest share in 2023
North America was the dominant region in 2023
Enable Injections, Inc., NOVO Engineering, Elcam Medical, Battelle, and Gerresheimer AG
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: On-body Drug Delivery Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. On-body Drug Delivery Devices Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global On-body Drug Delivery Devices Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2020-2034
6.3.1. Wearable Injectors
6.3.2. Auto-injectors
6.3.3. Patches
6.3.4. Others
6.4. Market Attractiveness Analysis, by Product Type
7. Global On-body Drug Delivery Devices Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2020-2034
7.3.1. Cardiovascular Diseases
7.3.2. Cancer
7.3.3. Autoimmune Diseases
7.3.4. Diabetes
7.3.5. Others (Orthopedic Disorders, etc.)
7.4. Market Attractiveness Analysis, by Application
8. Global On-body Drug Delivery Devices Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Hospitals
8.3.2. Specialty Clinics
8.3.3. Ambulatory Surgery Centers
8.3.4. Others (Research Institutes, etc.)
8.4. Market Attractiveness Analysis, by End-user
9. Global On-body Drug Delivery Devices Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America On-body Drug Delivery Devices Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product Type, 2020-2034
10.3.1. Wearable Injectors
10.3.2. Auto-injectors
10.3.3. Patches
10.3.4. Others
10.4. Market Value Forecast, by Application, 2020-2034
10.4.1. Cardiovascular Diseases
10.4.2. Cancer
10.4.3. Autoimmune Diseases
10.4.4. Diabetes
10.4.5. Others (Orthopedic Disorders, etc.)
10.5. Market Value Forecast, by End-user, 2020-2034
10.5.1. Hospitals
10.5.2. Specialty Clinics
10.5.3. Ambulatory Surgery Centers
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Product Type
10.7.2. By Application
10.7.3. By End-user
10.7.4. By Country
11. Europe On-body Drug Delivery Devices Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product Type, 2020-2034
11.3.1. Wearable Injectors
11.3.2. Auto-injectors
11.3.3. Patches
11.3.4. Others
11.4. Market Value Forecast, by Application, 2020-2034
11.4.1. Cardiovascular Diseases
11.4.2. Cancer
11.4.3. Autoimmune Diseases
11.4.4. Diabetes
11.4.5. Others (Orthopedic Disorders, etc.)
11.5. Market Value Forecast, by End-user, 2020-2034
11.5.1. Hospitals
11.5.2. Specialty Clinics
11.5.3. Ambulatory Surgery Centers
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Application
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific On-body Drug Delivery Devices Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product Type, 2020-2034
12.3.1. Wearable Injectors
12.3.2. Auto-injectors
12.3.3. Patches
12.3.4. Others
12.4. Market Value Forecast, by Application, 2020-2034
12.4.1. Cardiovascular Diseases
12.4.2. Cancer
12.4.3. Autoimmune Diseases
12.4.4. Diabetes
12.4.5. Others (Orthopedic Disorders, etc.)
12.5. Market Value Forecast, by End-user, 2020-2034
12.5.1. Hospitals
12.5.2. Specialty Clinics
12.5.3. Ambulatory Surgery Centers
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Application
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America On-body Drug Delivery Devices Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product Type, 2020-2034
13.3.1. Wearable Injectors
13.3.2. Auto-injectors
13.3.3. Patches
13.3.4. Others
13.4. Market Value Forecast, by Application, 2020-2034
13.4.1. Cardiovascular Diseases
13.4.2. Cancer
13.4.3. Autoimmune Diseases
13.4.4. Diabetes
13.4.5. Others (Orthopedic Disorders, etc.)
13.5. Market Value Forecast, by End-user, 2020-2034
13.5.1. Hospitals
13.5.2. Specialty Clinics
13.5.3. Ambulatory Surgery Centers
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Application
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa On-body Drug Delivery Devices Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Product Type, 2020-2034
14.3.1. Wearable Injectors
14.3.2. Auto-injectors
14.3.3. Patches
14.3.4. Others
14.4. Market Value Forecast, by Application, 2020-2034
14.4.1. Cardiovascular Diseases
14.4.2. Cancer
14.4.3. Autoimmune Diseases
14.4.4. Diabetes
14.4.5. Others (Orthopedic Disorders, etc.)
14.5. Market Value Forecast, by End-user, 2020-2034
14.5.1. Hospitals
14.5.2. Specialty Clinics
14.5.3. Ambulatory Surgery Centers
14.5.4. Market Value Forecast, by Country/Sub-region, 2020-2034
14.5.5. GCC Countries
14.5.6. South Africa
14.5.7. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. Enable Injections, Inc.
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. NOVO Engineering
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Elcam Medical
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Battelle
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Gerresheimer AG
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
List of Tables
Table 1: Global On-body Drug Delivery Devices Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 2: Global On-body Drug Delivery Devices Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 3: Global On-body Drug Delivery Devices Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 4: Global On-body Drug Delivery Devices Market Size (US$ Mn) Forecast, by Region, 2020-2034
Table 5: North America On-body Drug Delivery Devices Market Size (US$ Mn) Forecast, by Country, 2020-2034
Table 6: North America On-body Drug Delivery Devices Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 7: North America On-body Drug Delivery Devices Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 8: North America On-body Drug Delivery Devices Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 9: Europe On-body Drug Delivery Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe On-body Drug Delivery Devices Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 11: Europe On-body Drug Delivery Devices Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 12: Europe On-body Drug Delivery Devices Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 13: Asia Pacific On-body Drug Delivery Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific On-body Drug Delivery Devices Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 15: Asia Pacific On-body Drug Delivery Devices Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 16: Asia Pacific On-body Drug Delivery Devices Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 17: Latin America On-body Drug Delivery Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America On-body Drug Delivery Devices Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 19: Latin America On-body Drug Delivery Devices Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 20: Latin America On-body Drug Delivery Devices Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 21: Middle East & Africa On-body Drug Delivery Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa On-body Drug Delivery Devices Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 23: Middle East & Africa On-body Drug Delivery Devices Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 24: Middle East & Africa On-body Drug Delivery Devices Market Size (US$ Mn) Forecast, by End-user, 2020-2034
List of Figures
Figure 1: Global On-body Drug Delivery Devices Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034
Figure 2: Global On-body Drug Delivery Devices Market Revenue (US$ Mn), by Product Type, 2023
Figure 3: Global On-body Drug Delivery Devices Market Value Share, by Product Type, 2023
Figure 4: Global On-body Drug Delivery Devices Market Revenue (US$ Mn), by Application, 2023
Figure 5: Global On-body Drug Delivery Devices Market Value Share, by Application, 2023
Figure 6: Global On-body Drug Delivery Devices Market Revenue (US$ Mn), by End-user, 2023
Figure 7: Global On-body Drug Delivery Devices Market Value Share, by End-user, 2023
Figure 8: Global On-body Drug Delivery Devices Market Value Share, by Region, 2023
Figure 9: Global On-body Drug Delivery Devices Market Value (US$ Mn) Forecast, 2020-2034
Figure 10: Global On-body Drug Delivery Devices Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 11: Global On-body Drug Delivery Devices Market Attractiveness Analysis, by Region, 2024-2034
Figure 12: Global On-body Drug Delivery Devices Market Value Share Analysis, by Application, 2023 and 2034
Figure 13: Global On-body Drug Delivery Devices Market Attractiveness Analysis, by Application, 2024-2034
Figure 14: Global On-body Drug Delivery Devices Market Value Share Analysis, by End-user, 2023 and 2034
Figure 15: Global On-body Drug Delivery Devices Market Attractiveness Analysis, by End-user, 2024-2034
Figure 16: Global On-body Drug Delivery Devices Market Value Share Analysis, by Region, 2023 and 2034
Figure 17: Global On-body Drug Delivery Devices Market Attractiveness Analysis, by Region, 2024-2034
Figure 18: North America On-body Drug Delivery Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 19: North America On-body Drug Delivery Devices Market Attractiveness Analysis, by Country, 2024-2034
Figure 20: North America On-body Drug Delivery Devices Market Value Share Analysis, by Country, 2023 and 2034
Figure 21: North America On-body Drug Delivery Devices Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 22: North America On-body Drug Delivery Devices Market Value Share Analysis, by Application, 2023 and 2034
Figure 23: North America On-body Drug Delivery Devices Market Value Share Analysis, by End-user, 2023 and 2034
Figure 24: North America On-body Drug Delivery Devices Market Attractiveness Analysis, by Region, 2024-2034
Figure 25: North America On-body Drug Delivery Devices Market Attractiveness Analysis, by Application, 2024-2034
Figure 26: North America On-body Drug Delivery Devices Market Attractiveness Analysis, by End-user, 2024-2034
Figure 27: Europe On-body Drug Delivery Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 28: Europe On-body Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 29: Europe On-body Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 30: Europe On-body Drug Delivery Devices Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 31: Europe On-body Drug Delivery Devices Market Value Share Analysis, by Application, 2023 and 2034
Figure 32: Europe On-body Drug Delivery Devices Market Value Share Analysis, by End-user, 2023 and 2034
Figure 33: Europe On-body Drug Delivery Devices Market Attractiveness Analysis, by Region, 2024-2034
Figure 34: Europe On-body Drug Delivery Devices Market Attractiveness Analysis, by Application, 2024-2034
Figure 35: Europe On-body Drug Delivery Devices Market Attractiveness Analysis, by End-user, 2024-2034
Figure 36: Asia Pacific On-body Drug Delivery Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 37: Asia Pacific On-body Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 38: Asia Pacific On-body Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 39: Asia Pacific On-body Drug Delivery Devices Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 40: Asia Pacific On-body Drug Delivery Devices Market Value Share Analysis, by Application, 2023 and 2034
Figure 41: Asia Pacific On-body Drug Delivery Devices Market Value Share Analysis, by End-user, 2023 and 2034
Figure 42: Asia Pacific On-body Drug Delivery Devices Market Attractiveness Analysis, by Region, 2024-2034
Figure 43: Asia Pacific On-body Drug Delivery Devices Market Attractiveness Analysis, by Application, 2024-2034
Figure 44: Asia Pacific On-body Drug Delivery Devices Market Attractiveness Analysis, by End-user, 2024-2034
Figure 45: Latin America On-body Drug Delivery Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 46: Latin America On-body Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 47: Latin America On-body Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 48: Latin America On-body Drug Delivery Devices Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 49: Latin America On-body Drug Delivery Devices Market Value Share Analysis, by Application, 2023 and 2034
Figure 50: Latin America On-body Drug Delivery Devices Market Value Share Analysis, by End-user, 2023 and 2034
Figure 51: Latin America On-body Drug Delivery Devices Market Attractiveness Analysis, by Region, 2024-2034
Figure 52: Latin America On-body Drug Delivery Devices Market Attractiveness Analysis, by Application, 2024-2034
Figure 53: Latin America On-body Drug Delivery Devices Market Attractiveness Analysis, by End-user, 2024-2034
Figure 54: Middle East & Africa On-body Drug Delivery Devices Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 55: Middle East & Africa On-body Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 56: Middle East & Africa On-body Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 57: Middle East & Africa On-body Drug Delivery Devices Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 58: Middle East & Africa On-body Drug Delivery Devices Market Value Share Analysis, by Application, 2023 and 2034
Figure 59: Middle East & Africa On-body Drug Delivery Devices Market Value Share Analysis, by End-user, 2023 and 2034
Figure 60: Middle East & Africa On-body Drug Delivery Devices Market Attractiveness Analysis, by Region, 2024-2034
Figure 61: Middle East & Africa On-body Drug Delivery Devices Market Attractiveness Analysis, by Application, 2024-2034
Figure 62: Middle East & Africa On-body Drug Delivery Devices Market Attractiveness Analysis, by End-user, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
On-body Drug Delivery Devices Market
